Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models.
Mol Cancer Ther
; 19(1): 270-281, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31597714
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bridged-Ring Compounds
/
Receptor, EphA2
/
Taxoids
/
Programmed Cell Death 1 Receptor
/
Neoplasms
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Year:
2020
Document type:
Article